GB Sciences, Inc. (GBLX)
0.0003
0.00 (0.00%)
USD |
OTCM |
Feb 06, 16:00
GB Sciences Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Plus Therapeutics, Inc. | 19.14M |
| BioStem Technologies, Inc. | 80.84M |
| Iovance Biotherapeutics, Inc. | 756.02M |
| Protokinetix, Inc. | 2.036M |
| Travere Therapeutics, Inc. | 2.733B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.1004M |
| Revenue (Quarterly) | 0.0972M |
| Total Expenses (Quarterly) | 0.1976M |
| EPS Diluted (Quarterly) | -0.0002 |